Technology & Innovation
Share your love
Global trial equity: How LMIC data is reshaping US ophthalmology research | Ophthalmology Times
Incorporating data from low- and middle-income countries may help redefine how ophthalmology trials are designed, evaluated, and applied in practice (Image credit: AdobeStock/PUTRABATARA) Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins…
FDA approvals in 2025: What changed and why it matters for ophthalmologists | Ophthalmology Times
Editor’s Note: This content was generated with the assistance of AI. From first-in-class pharmacologic therapies to next-generation retinal durability strategies and less invasive surgical platforms, 2025 emerged as a pivotal year for the ophthalmic pipeline. Over the past 12 months,…
Q&A: What changed in residency education in 2025? Perspectives from training directors | Ophthalmology Times
Residency programs are adapting to evolving training requirements, new technologies, and changing trainee needs to better prepare future ophthalmologists. (Image credit: AdobeStock/WavebreakMediaMicro) Ophthalmology residency training is constantly evolving, and 2025 marked a year of notable developments that are shaping how…
Glaucoma 2026: Which emerging technologies will change practice? | Ophthalmology Times
In this latest EyePod podcast episode, Joel Schuman, MD, of Wills Eye Hospital in Philadelphia, sits down with Sheryl Stevenson, executive editor with the Eye Care Network, to discuss emerging technologies that may influence glaucoma practice as clinicians look to…
AI in ophthalmology research: Ethical implications for medical students | Ophthalmology Times
Training students to use AI responsibly ensures effective, ethical integration into research and medical education. (Image credit: AdobeStock/ABDULELLAH) Over the past decade, earning an ophthalmology residency spot has become more difficult and competitive.1 Between 2021 and 2024, the overall match…
The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Dante Pieramici, MD, FASRS; Dean Eliott, MD; and Charles C. Wykoff, MD, PhD, FASRS; provide an overview of macular…
Customized Clarity: Navigating IOL Options for Optimal Patient Care | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Tanner Ferguson, MD, and Taj Nasser, MD, FWCRS, discuss the management of astigmatism at the time of cataract surgery,…
How AI is reshaping ophthalmology in 2025 and beyond | Ophthalmology Times
(Image Credit: AdobeStock/ImageFlow) Artificial intelligence (AI) continues to evolve with improved diagnostic abilities, individualized patient treatments, and enhanced surgical accuracy. Some key developments include the analysis of retinal scans that provide earlier disease detection and the ability to spot tumors…
The Atrophy Advisor: An online tool to inform GA treatment decisions | Ophthalmology Times
(Image Credit: AdobeStock/NINENII) An online tool, Atrophy Advisor, was developed to guide physicians regarding treatments for patients with geographic atrophy (GA) associated with age-related macular degeneration (AMD). The tool, available at atrophyadvisor.com, integrates GA progression and personalized lifespan estimates to…
Spotlight on women’s health: Understanding thyroid eye disease | Ophthalmology Times
Image by Jennifer Toomey/MJH Life Sciences using AI Thyroid eye disease (TED), also known as Graves ophthalmopathy or Graves eye disease, is an autoimmune condition in which the immune system targets tissues related to the thyroid.1 This leads to inflammation…